Jaguar Health (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Jaguar Health

BRIEF

published on 08/19/2024 at 16:05, 3 months 1 day ago

Jaguar Health obtient un nouveau brevet pour Crofelemer à Hong Kong

Crofelemer Brevet Médicaments Santé Jaguar Syndrome De L'intestin Court
BRIEF

published on 08/19/2024 at 16:05, 3 months 1 day ago

Jaguar Health Secures New Patent for Crofelemer in Hong Kong

Crofelemer Short Bowel Syndrome Pharmaceuticals Patent Jaguar Health
PRESS RELEASE

published on 08/19/2024 at 16:00, 3 months 1 day ago

Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer by Jaguar Health, enhancing intellectual property protection. Proof-of-concept studies ongoing for SBS and MVID

Crofelemer Patent Jaguar Health Rare Disease Proof-of-Concept Studies
BRIEF

published on 08/13/2024 at 14:05, 3 months 7 days ago

Jaguar Health publie ses résultats financiers du deuxième trimestre 2024

Résultats Financiers Santé Jaguar Essais De Phase 3 Chiffre D'affaires 2024 Produits Sur Ordonnance
BRIEF

published on 08/13/2024 at 14:05, 3 months 7 days ago

Jaguar Health Reports Second Quarter 2024 Financial Results

Financial Results Jaguar Health Phase 3 Trials 2024 Revenue Prescription Products
PRESS RELEASE

published on 08/13/2024 at 14:00, 3 months 7 days ago

Jaguar Health Reports Second Quarter 2024 Financial Results
Jaguar Health, Inc. reports a 16% revenue increase in Q2 2024 for prescription and non-prescription products. Company explores approval pathways for crofelemer in rare diseases, plans commercial launch of Gelclair in October 2024

Revenue Increase Crofelemer Jaguar Health Q2 2024 Gelclair
BRIEF

published on 08/01/2024 at 15:05, 3 months 19 days ago

Crofelemer de Jaguar Health montre des résultats prometteurs pour la diarrhée chronique

Crofelemer Essais Cliniques Gastro-entérologie Diarrhée Fonctionnelle Diarrhée Chronique
BRIEF

published on 08/01/2024 at 15:05, 3 months 19 days ago

Jaguar Health's Crofelemer Shows Promising Results for Chronic Diarrhea

Crofelemer Clinical Trials Gastroenterology Functional Diarrhea Chronic Diarrhea
PRESS RELEASE

published on 08/01/2024 at 15:00, 3 months 19 days ago

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting
Napo Pharmaceuticals announced positive results of studies on crofelemer for chronic refractory diarrhea at the ACG Annual Scientific Meeting. The drug may benefit patients with functional diarrhea and chronic idiopathic diarrhea

Napo Pharmaceuticals Crofelemer Functional Diarrhea ACG Annual Scientific Meeting Chronic Refractory Diarrhea
BRIEF

published on 07/31/2024 at 16:05, 3 months 20 days ago

La délivrance d'un nouveau brevet européen renforce la protection de la propriété intellectuelle de Jaguar Health dans le traitement des troubles diarrhéiques congénitaux (CDD)

Crofelemer Santé Jaguar Brevet Européen CDD Études De Validation De Principe

Accesswire

Published on 11/21/2024 at 09:00, 41 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 6 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 16 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 41 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 41 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 40 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 41 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 41 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 26 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 32 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 43 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 34 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 21 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE